Clover Health Investments Corp. (NASDAQ:CLOV) finished Wednesday with an addition of $0.03 to close at $8.05, an upside of 0.37 percent. An average of 14,898,320 shares of common stock have been traded in the last five days. There was a gain of $0.69 in the past week. The last 20 days have seen an average of 16,234,240 shares traded, while the 50-day average volume stands at 26,542,021.
CLOV stock has decreased by -3.01% in the last month. The company shares reached their 1-month lowest point of $7.07 on 10/06/21. With the stock rallying to its 52-week high on 06/09/21, shares of the company touched a low of $6.31 and a high of $28.85 in 52 weeks. In spite of this, the price is down -72.10% from the 52-week high.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Clover Health Investments Corp. (CLOV) has a trailing price-to-earnings (P/E) ratio of 22.90 for the broader industry and 32.30 for the sector. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 3.13, the price-to-book (PB) ratio at 10.59.
The quick ratio of Clover Health Investments Corp. for the three months ended June 29 was 3.70, and the current ratio was 3.70, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.06 and a total debt to equity ratio of 0.00 for the quarter ending June 29.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Clover Health Investments Corp.’s return on assets was -39.60%. For the broader industry, ROE averaged 16.45 over the past year.
The analyst consensus anticipated Clover Health Investments Corp.’s latest quarter earnings to come in at -$0.13 per share, but it turned out to be -$0.78, a -500.00% surprise. For the quarter, EBITDA amounted to -$181.67 million. Shareholders own equity worth $410.61 million.
From a technical analysis perspective, let’s take a brief look at Clover Health Investments Corp. (CLOV) price momentum. RSI 9-day as of the close on 13 October was 57.66%, suggesting the stock is Neutral, with historical volatility in this time frame at 40.44%.
As of today, CLOV’s price is $7.88 +9.38% or $0.69 from its 5-day moving average. CLOV is currently trading -1.47% lower than its 20-day SMA and +16.16% higher than its 100-day SMA. However, the stock’s current price level is -0.86% below the SMA50 and -52.84% below the SMA200.
The stochastic %K and %D were 80.41% and 72.25%, respectively, and the average true range (ATR) was 0.42. With the 14-day stochastic at 80.96% and the average true range at 0.47, the RSI (14) stands at 51.72%. The stock has reached 0.42 on the 9-day MACD Oscillator while the 14-day reading was at 0.40.
Cowen launched coverage on Clover Health Investments Corp. (NASDAQ: CLOV) in its analyst report released on September 10, 2021. The firm assigned the stock a an Underperform rating.The consensus rating for Clover Health Investments Corp. (CLOV) among analysts is Underweight. According to current brokerage recommendations, 2 brokerage firms advise that investors sell CLOV, while 2 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 0 others rate it as a “buy”.
What is CLOV’s price target for the next 12 months?
Analysts predict a range of price targets between $7.00 and $10.00, with a median target of $9.00. Taking a look at these predictions, the average price target given by analysts for Clover Health Investments Corp. (CLOV) stock is $9.00.